Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors. [electronic resource]
- Cerebrovascular diseases (Basel, Switzerland) 2001
- 85-95 p. digital
Publication Type: Journal Article; Review
1015-9770
10.1159/000049130 doi
Brain Ischemia--drug therapy Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use Hypolipidemic Agents--therapeutic use